Tuberculosis: new drug class investigated through public-private partnership.
D000995:Antitubercular Agents / Q000627:therapeutic use*; D003299:Cooperative Behavior; D006801:Humans; D009593:Nitroimidazoles / Q000627:therapeutic use*; D017149:Private Sector; D017150:Public Sector; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D009593:Nitroimidazoles; C410767:pretomanid